// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Initial Stroke Severity Measured by Pediatric NIH Stroke Scale Predicts 12-month Outcome in Children

Rachel A. Bastian - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Sex Differences in CD200 and CD200R1 Expression in the Brain Following Experimental Stroke

Craig S Moore - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Neuronal injury

N/A

Omeprazole, A Potent Cyp 2c19 Inhibitor, Does Not Alter The Pharmacokinetics Or Platelet Aggregation Of Asa And Dipyridamole In Combination

Rolf Rolf-Stefan - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

dipyridamole

From Data to Action: Improving Knowledge Translation through Ontari-s Stroke Report Cards

Ferhana Khan - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Acute Stroke opens Neuronal Pannexin1 Channels

Nicole Peterson - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

Probenecid

Perfusion imaging predicts Outcome in TIA and Minor Stroke. A Prospective Derivation-Validation Study

Jonathan I Coulter - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

MR Imaging Of The Intracranial Vessel Wall In Paediatric Stroke

Ivanna Yau - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Investigating Gender Differences in Secondary Stroke Prevention Care in Ontario

Kathryn Hodwitz - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Trends in the Incidence, Types and Outcomes of Intracerebral Hemorrhage in Ontario from 1990 - 2010

Jiming Fang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

Warfarin

Apixaban Compared To Aspirin In Patients With Atrial Fibrillation And Prior Transient Ischemic Attack Or Stroke: Results Of A Predefined Subgroup Analysis From Averroes

John Eikelboom - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

apixaban

Reasons To Withhold Anticoagulation In Atrial Fibrillation Subjects After Ischemic Stroke

Jesse D Coull - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Warfarin

High Rate Of Radiographic Stroke Recurrence In Cryptogenic TIA And Minor Stroke Patients: A Prospective Imaging Study

Shiel K Patel - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Distal Occlusions And Smaller Clots Show High Early Recanalization Rates With iv tPA: Pilot Data From The Multi-center Interrsect Study.

Sung-Il Sohn - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Does the Volume of Stroke/TIA Admissions Relate to Clinical Outcomes in the Ontario Stroke System?

Jiming Fang - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ischemic stroke

N/A

Anterior Choroidal Artery Involvement Is Predictor Of Poor Neurological Outcomes In Distal Carotid Occlusions

Bijoy Menon - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Eloquence Of Region And Extent Of Brain Ischemia Detected By DWI Predicts Degree Of 24h Nihss Score Improvement After Arterial Recanalization In Ischemic Stroke

Sanjith Aaron - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Contrast Permeation In Hyperdense Artery Sign: Evidence Of Freshly Forming Thrombus Accumulating Around The Initial Clot? Pilot Data From The Interrsect Multicentre Thrombus Imaging Study.

Sung-Il Sohn - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Structural Integrity of the Corticospinal Tract Correlated with the Degree of Hand Recovery in Pediatric Patients Following Stroke

David Mikulis - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Clinical, Biochemical and Genetic Predictors of Late Coronary Artery Bypass Graft Failure

Khaled D Algarni - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

glutathione

Evolution of the Arterial Structure and Function from Infancy to Adolescence is related to Anthropometric and Blood Pressure Changes

Cedric Manlhiot - American Heart Association (AHA) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

N/A

Copyright © 2026. QuantiNova All rights reserved